Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency
- Supplementary File 1:
ZIP-Document (ZIP, 650 KiB)
Sinegubova, M.; Vorobiev, I.; Klishin, A.; Eremin, D.; Orlova, N.; Orlova, N.; Polzikov, M. Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency. Pharmaceutics 2022, 14, 96. https://doi.org/10.3390/pharmaceutics14010096
Sinegubova M, Vorobiev I, Klishin A, Eremin D, Orlova N, Orlova N, Polzikov M. Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency. Pharmaceutics. 2022; 14(1):96. https://doi.org/10.3390/pharmaceutics14010096
Chicago/Turabian StyleSinegubova, Maria, Ivan Vorobiev, Anatoly Klishin, Dmitry Eremin, Nadezhda Orlova, Natalya Orlova, and Mikhail Polzikov. 2022. "Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur®) to Yield a Pharmaceutical Product with High Batch-to-Batch Consistency" Pharmaceutics 14, no. 1: 96. https://doi.org/10.3390/pharmaceutics14010096